Mapping large numbers of results may take a few moments.
Search Results
Showing 1 - 29 of 29 results found.
Company | Activity | Company Description | Location | |
---|---|---|---|---|
Company AlphaVax Inc. | Activity: Research and Development | Company Description AlphaVax develops vaccine technology with applications in infectious disease, cancer and biodefense threats. | Location Research Triangle Park | |
Company AthemBio | Activity: Research and Development | Company Description AthemBio is developing technology to isolate and purify therapeutic antibodies to treat COVID-19 and other pathogenic outbreaks. | Location Durham | |
Company Atom Bioworks Inc. | Activity: Research and Development | Company Description Atom Bioworks has developed a platform for programming DNA/RNA-based biomolecules as high-affinity binding reagents. | Location Cary | |
Company Bavarian Nordic Inc. | Activity: Research and Development | Company Description Bavarian Nordic develops, manufactures and commercializes vaccines for infectious diseases. | Location Durham | |
Company BioCryst Pharmaceuticals Inc. | Activity: Research and Development | Company Description BioCryst Pharmaceuticals designs and develops novel, small-molecule oral drugs that block key enzymes to treat rare diseases. The Durham location houses BioCryst's clinical, regulatory and executive teams. | Location Durham | |
Company BioMedomics Inc. | Activity: Research and Development | Company Description BioMedomics develops and manufactures point-of-care (POC) diagnostics in hematology oncology, virology, women’s health and dermatology. | Location Morrisville | |
Company Cellex Inc. | Activity: Research and Development | Company Description Cellex develops, manufactures and markets diagnostic tests suitable for point-of-care use. These tests use a platform technology called Homogeneous Biochemiluminescence Assay (HBA), which enables assays that are highly sensitive and easy-to-use. | Location Cary | |
Company Chimerix Inc. | Activity: Research and Development | Company Description Chimerix discovers, develops and commercializes broad spectrum antivirals for the prevention and treatment of life-threatening viral infections. | Location Durham | |
Company Citranvi Biosciences LLC | Activity: Research and Development | Company Description Citranvi develops vaccine technology platforms and products, using comprehensive structure-based vaccine design, broadly applicable to a variety of viral pathogens such as Cytomegalovirus, Epstein-Barr Virus and Coronaviruses. | Location Chapel Hill | |
Company Domus Diagnostics | Activity: Research and Development | Company Description Domus Diagnostics is a point-of-care diagnostics company that develops accurate, rapid molecular tests for infectious diseases. | Location Durham | |
Company ENVIGEN Pharmaceuticals Inc. | Activity: Research and Development | Company Description ENVIGEN develops classes of small drug-like molecules to treat life-threatening diseases including cancer, HIV/AIDS and neurological disorders. | Location Durham | |
Company Genencine Therapeutics LLC | Activity: Research and Development | Company Description Genencine Therapeutics develops mRNA vaccines for the prevention and treatment of cancer, viral diseases and autoimmune diseases, as well as mRNA therapeutic drugs for genetic diseases. | Location Durham | |
Company Global Vaccines Inc. | Activity: Research and Development | Company Description Global Vaccines is a not-for-profit company that develops vaccines against developing-country diseases such as HIV/AIDS, polio, dengue fever, malaria and viral diarrhea (rotavirus). | Location Chapel Hill | |
Company GreenLight Biosciences Inc. | Activity: Research and Development | Company Description Greenlight Biosciences has developed a cell-free bioprocessing method for the low-cost production of RNA for use in research in vaccine development, vector control, pandemic preparation, crop management and crop pesticides. | Location Research Triangle Park | |
Company GSK (Durham) | Activity: Research and Development | Company Description GSK develops and manufactures vaccines and medicines, with a focus on science related to the immune system, human genetics and advanced technologies. | Location Durham | |
Company IMMvention Therapeutix Inc. | Activity: Research and Development | Company Description IMMvention develops small molecule therapies that inhibit multiple inflammasome receptors to treat both rare and prevalent inflammatory diseases. | Location Research Triangle Park | |
Company Jericho Sciences LLC | Activity: Research and Development | Company Description Jericho Sciences is developing antiviral therapeutics and corresponding personalized diagnostic assays which specifically address the limitations of current combination antiretroviral therapy (cART) in the clinical management of HIV-1 infection to reduce underlying sources of persistent virus. | Location Durham | |
Company Mucommune LLC | Activity: Research and Development | Company Description Mucommune is developing a platform using monoclonal antibodies and mucus to reinforce the mucus barrier for female reproductive health. | Location Durham | |
Company MultiSeq Inc. | Activity: Research and Development | Company Description MultiSeq out-licenses molecular diagnostics platform technologies for cancer and infectious disease diagnosis. | Location Greensboro | |
Company PhotoCide Protection Inc. | Activity: Research and Development | Company Description PhotoCide Protection develops self-disinfecting materials based on technology combining engineered cellulose with photosensitizers which emit singlet oxygen, an environmentally-friendly biocidal agent which destroys pathogens on surfaces. | Location Apex | |
Company Precision BioSciences Inc. (Durham) | Activity: Research and Development | Company Description Precision BioSciences is a clinical stage in vivo gene editing company using its novel ARCUS genome editing platform to develop new treatment options for genetic and infectious diseases. | Location Durham | |
Company Qura Therapeutics LLC | Activity: Research and Development | Company Description Qura Therapeutics is discovering therapeutics for curing HIV/AIDS. Qura is a joint venture between ViV Healthcare and UNC-CH and provides financial, material and development support for therapies that emerge from research at the UNC HIV Cure Center. | Location Chapel Hill | |
Company RAIN Scientific Inc. | Activity: Research and Development | Company Description Rain Scientific is developing technologies to combat pathogens such as COVID-19 and drug resistant bacteria. | Location Cornelius | |
Company Resilient Biotics Inc. | Activity: Research and Development | Company Description Resilient Biotics is developing non-antibiotic, microbiome-based therapeutics to combat complex respiratory infections with applications in human and animal health. Resilient utilizes a proprietary discovery platform for product development and has a broad pipeline across multiple species. | Location Durham | |
Company Trana Discovery Inc. | Activity: Research and Development | Company Description Trana Discovery provides an anti-infective discovery platform that enables its partners to identify novel treatments with pathogen-focused spectrums of activity for bacterial, viral and fungal infectious diseases by inhibiting tRNA not possessed by humans or crops. | Location Cary | |
Company United Therapeutics Corp. (RTP HQ) | Activity: Research and Development | Company Description United Therapeutics develops and commercializes products to treat cardiopulmonary diseases, infectious diseases and cancer. | Location Research Triangle Park | |
Company ViiV Healthcare | Activity: Research and Development | Company Description ViiV Healthcare, a joint venture established by GSK and Pfizer, researches and develops new HIV medicines and advances care for people living with HIV. | Location Durham | |
Company ViroKyne Therapeutics LLC | Activity: Research and Development | Company Description Virokyne is developing novel therapies for the treatment of viral diseases. | Location Durham | |
Company Zymeron Corporation | Activity: Research and Development | Company Description Zymeron develops and commercialize technologies to detect, prevent and treat infectious diseases, immune disorders and emerging pathological threats. | Location Durham |